CNTX   $1.4  -6.67% Market Closed After Close 1.32 -5.71%

Context Therapeutics Inc
Total Cash 101.54M
totalCashPerShare 1.354
EBITDA -20.01M
Total Debt 0.00
quickRatio 63.289
currentRatio 64.013
Total Revenue
debtToEquity
Revenue/Share
ROA -0.19186
ROE -0.29681
grossProfits
freeCashflow -12.33M
operatingCashflow -18.40M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 64.96M
forwardPE -7.655173
floatShares 39.07M
sharesOutstanding 75.00M
sharesShort 1.03M
sharesShortPriorMonth 1.69M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.76%
Short Ratio help_outline 2.79%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 1.348
Price To Book help_outline 1.65
earningsQuarterlyGrowth
netIncomeToCommon -18.57M
trailingEps -0.96%
forwardEps -0.29%
enterpriseToEbitda -3.25
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.1 3Q 2024
institutionsCount 38
lastUpdated Nov. 7, 2024, 5:12 a.m.